ey0017.5-4 | Advances in Clinical Practice | ESPEYB17
KE Ackerman
, V Singhal
, M Slattery
, KT Eddy
, ML Bouxsein
, H Lee
, A Klibanski
, M Misra
To read the full abstract: J Bone Miner Res. 2020;35(2):248260.In brief: This randomized open-label trial in oligoamenorrheic athletes evaluated the effects of transdermal estrogen, oral estrogen or no replacement on bone metabolism, geometry, and microarchitecture. Transdermal estrogen treatment resulted in significantly greater increases in volumetric bone mineral d...